About 908 Devices
908 Devices is a publicly listed company based in Boston (United States) founded in 2012. Handheld chemical detection devices are manufactured using mass spectrometry. 908 Devices has raised $68.22 million across 8 funding rounds from investors including SLB, Arch Venture Partners and Sands Capital Ventures. The company has 246 employees. 908 Devices has completed 2 acquisitions, including RedWave Technology and TRACE Analytics. Its website 908devices.com draws about 15 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems. Its competitors include Advion, Impedimed and Zeteo Tech; 3 of its 3 listed competitors have raised funding.
Company details
908 Devices was founded in 2012 in Boston, United States, within the biotechnology and chemical analysis sector. Battery-operated, handheld detection tools and personal analyzers are produced for use by biologists and chemists. Mass spectrometry technology is employed in product development for applications including safety and security, food science, biotechnology, clinical diagnostics, and industrial process control. Operations focus on portable solutions for laboratory and field-based chemical analysis.
- Headquarters Boston, United States
- Employees 246
- Stage Public
- SectorsHealthcare
- Website 908devices.com
- Social LinkedIn X Facebook YouTube
- Legal Name 908 Devices Inc.
- Annual Revenue$56.2 M (USD)17.7as on Dec 31, 2025
- Net Profit-$36.64 M (USD)49.26as on Dec 31, 2025
- EBITDA-$19.71 M (USD)21.98as on Dec 31, 2025
- Total Equity Funding$68.22M (USD)
in 8 rounds
- Latest Funding Round$17.5M (USD), Series E
Apr 2019
- InvestorsSLB
& 10 more
- Employee Count246
- Investments & AcquisitionsRedWave Technology
& 1 more
Apps and channels of 908 Devices
its YouTube channel 908 Devices has 230 subscribers and 27 videos.
Videos from 908 Devices
The most watched videos on 908 Devices's YouTube channel, 908 Devices (230 subscribers). Click a video to play it here.
More on 908 Devices.
Funding Insights of 908 Devices
908 Devices has successfully raised a total of $68.22M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $17.5 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $68.22M
- Total Rounds 8
- Last Round Series E — $17.5M
- First Round $8.12M
(Aug 2012)
- Investors Count 11
All 8 funding rounds of 908 Devices with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2019 | $17.5M | Series E | – | Northpond Ventures | |
| Sep 2018 | $24M | Series C | – | Tao Capital Partners | |
| Jun 2016 | Series C | – | – | – | |
| May 2015 | $11.6M | Series C | – | Aramco Ventures | |
| Sep 2014 | $2.6M | Grant | – | – | |
| Aug 2013 | $7M | Series B | – | Schlumberger | |
| Apr 2013 | Series B | – | In-Q-Tel | – | |
| Aug 2012 | $8.12M | Series A | – | Arch Venture Partners |
11 investors in total: 11 institutional.
Investors in 908 Devices
908 Devices has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include SLB, Arch Venture Partners and Sands Capital Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth stage tech & life sciences focused VC Firm investing in Asia and the US | sandscapitalventures.com | Arlington, United States | ||
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Multi-stage venture capital investments are made in US sectors. | razorsvc.com | Reston, United States | ||
Venture capital firm focused on multiple sectors | taocap.com | Marlborough, United States | ||
Investing in Life Sciences sectors like Healthcare and Biotechnology. | casdincapital.com | |||
Early-stage startups are targeted for investment by Aramco Ventures. | aramcoventures.com | Dhahran, Saudi Arabia | ||
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
Seed and Early stage VC firm investing in Japan | ut-ec.co.jp | Tokyo, Japan | ||
Venture capital firm | iqt.org | Washington, Dc, United States | ||
Oilfield services and products are supplied worldwide by Schlumberger. | 1926 | slb.com | United States |
Investor details for 908 Devices
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of 908 Devices
61 people are tracked at 908 Devices (13 in leadership, 23 in board & advisors, 25 in team); the tracked headcount is 246.
| Name | Role | Group |
|---|---|---|
Kevin J. Knopp | CEO & Co-founder | Leadership |
Michael Turner | Chief Legal & Administrative Officer | Leadership |
Steve Davenport | VP, Commercial Sales | Leadership |
Andrew Bartfay | Co-Founder & Director, Hardware Development | Leadership |
John Kenneweg | VP, Government | Leadership |
Don Osmer | VP, Human Resources | Leadership |
George Goodliffe | Vice President, North America Life Science Sales And Field Marketing | Leadership |
Joe Griffith | Chief Financial Officer | Leadership |
Barbara Russo | Vice President, Marketing & Corporate Communications | Leadership |
Michele Fournier | Chief People Officer | Leadership |
Kevin McCallion | VP, Production & NPI | Leadership |
Trey Sieger | Senior Director, International Business | Leadership |
Joseph H. Griffith | CFO | Leadership |
Renã Robinson | Advisor | Board & advisors |
Mark Spoto | Director | Board & advisors |
Jarrod Marto | Advisor | Board & advisors |
Fenel Eloi | Director | Board & advisors |
Tim Charlebois | Advisor | Board & advisors |
Joshua Coon | Advisor | Board & advisors |
Tony J. Hunt | Director | Board & advisors |
41 more people are available in the full profile.
Complete people profiles for 908 Devices
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of 908 Devices
908 Devices is a publicly listed company on the NASDAQ with ticker symbol MASS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Dec 2020
- Listed onNASDAQ: MASS
- Listed entity908 Devices Inc.
- Exchange sectorHealth technology
- ISINUS65443P1021
- Share price$12.09 (+2.28% on the day) · 2026-10-13
- Market capitalisation$499.7M
- EPS (diluted, trailing year)$-0.94
- Volume (last session)230,404
Financials of 908 Devices
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $56.2M | -$36.6M | -$19.7M |
| 2024 | $47.8M | -$72.2M | -$25.3M |
| 2023 | $50.2M | -$36.4M | -$40.0M |
| 2022 | $46.9M | -$33.6M | -$33.6M |
| 2021 | $42.2M | -$22.2M | -$21.1M |
Detailed financial statements for 908 Devices
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 908 Devices
908 Devices has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include RedWave Technology and TRACE Analytics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of commercial security services | redwavetech.com | Danbury, United States | 2004 | Apr 2024 | •••• | |
Biosensors for online monitoring of biotechnology cultivation processes are developed. | trace.de | Braunschweig, Germany | 2003 | Aug 2022 | $15.3M |
Complete acquisition details for 908 Devices
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of 908 Devices
6 dated milestones of 908 Devices across 12 years, from founding to its latest funding, stage changes and deals.
- Founded 908 Devices is founded.
- Funding First funding round of $8.1M.
- Funding Latest funding round, Series E, of $17.5M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires TRACE Analytics.
- Acquisition Acquires RedWave Technology.
Competitors of 908 Devices
908 Devices has 3 listed competitors in our database, 3 of them funded. They include Advion, Impedimed and Zeteo Tech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| impedimed.com | 1999 | Carlsbad, United States | $3.44M | 76 | Technologies for non-invasive fluid status assessment and monitoring are developed. | |
| zeteotech.com | 2013 | Sykesville, United States | $2M | 21 | Biological mass spectrometers are manufactured for airborne microbe detection. |
Detailed competitors of 908 Devices
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of 908 Devices
The website of 908 Devices (908devices.com) receives about 15.4K visits a month.
- Monthly visits15.4K
▲ 14.1% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as 908 Devices (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about 908 Devices
Complete news archive for 908 Devices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 908 Devices
908 Devices was founded in 2012.
908 Devices is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
908 Devices is a funded company, having raised a total of $68.22M across 8 funding rounds to date. The company's 1st funding round was a Series A of $8.12M, raised on Aug 2012.
908 Devices has 246 employees.
Annual revenue of 908 Devices is $56.2M as on Dec 31, 2025.
908 Devices was founded in 2012 in Boston, United States, within the biotechnology and chemical analysis sector. Battery-operated, handheld detection tools and personal analyzers are produced for use by biologists and chemists. Mass spectrometry technology is employed in product development for applications including safety and security, food science, biotechnology, clinical diagnostics, and industrial process control. Operations focus on portable solutions for laboratory and field-based chemical analysis.
908 Devices's top competitors include Impedimed, Advion and Zeteo Tech.
Yes, 908 Devices is publicly traded on NASDAQ under the ticker symbol MASS.
908 Devices has made 2 acquisitions, including RedWave Technology, and TRACE Analytics.
908 Devices has 11 investors. Key investors include SLB, Arch Venture Partners, Sands Capital Ventures, Razor's Edge Ventures, and Tao Capital Partners.